Many older people have this under-diagnosed lung disease, study shows
In a new study report, researchers discuss the prevalence, incidence, and impact of chronic obstructive pulmonary disease (COPD) in older adults.
The study provides insight...
This stuff in body can cause blood clotting, severe COVID-19
In a new study, researchers found a protein that can cause blood clotting and contribute to severe COVID-19.
The research was conducted by a team...
Reducing ‘bad’ cholesterol may not help cut heart disease risk
In a new study, researchers found that setting targets for 'bad' (LDL) cholesterol levels to ward off heart disease and death in those at...
Drug that calms ‘cytokine storm’ linked to 45% lower death risk in severe COVID-19
Patients who received single intravenous dose of tocilizumab were also more likely to leave the hospital or be off a ventilator within a month,...
How diabetes and obesity affect the brain
With more than 30 million Americans diagnosed with diabetes, and another 87 million diagnosed with obesity, both conditions have become national epidemics.
The two diseases...
Ancient part of immune system may boost severe COVID-19
In a new study, researchers found that one of the immune system's oldest branches, called complement, may be influencing the severity of COVID-19 disease.
Among...
Childhood trauma may make your body and brain age faster, Harvard study shows
In a new study, researchers found children who suffer trauma from abuse or violence early in life show biological signs of aging faster than...
How COVID-19 changed the way people responded to a heart attack
In a new study, researchers found that the death rate for people who experienced what is normally a lower-risk heart attack rose sharply during...
This stuff in blood may predict lung cancer and colon cancer risks in men
In a new study, researchers found that blood platelet counts at the higher end of normal suggest a high risk of cancer in men...
Scientists do not make strong recommendation for drug remdesivir in severe COVID-19
In a new paper, researchers make a weak recommendation for the use of remdesivir in patients with severe COVID-19, and strongly support continued testing...